The STI Testing Challenge in Healthcare
Sexually transmitted infections (STIs) remain a critical public health challenge. In 2024, the CDC reported 2.2 million new STI cases in the US alone, with many cases going untreated due to diagnostic delays and cost barriers. For healthcare operations managers at urgent care centers, FQHCs, and small hospital systems, the choice of STI lab partner directly impacts three critical metrics:
- Turnaround time (TAT) – How fast patients get results and can start treatment
- Cost per test – What you actually pay (often hidden in opaque billing)
- Quality metrics – Reject rates, processing reliability, SLA compliance
Yet most clinics operate with a single lab partner, locked into a one-size-fits-all contract with no visibility into whether they're overpaying or underperforming. This guide explores how to rethink lab sourcing and build a more efficient, cost-effective testing strategy.
Understanding Cost-Per-Reportable-Result (CPRR) Pricing
What is CPRR?
Cost-Per-Reportable-Result (CPRR) is a transparent, all-in pricing model where you pay a fixed price for each finalized, clinically reportable test result. Unlike traditional lab billing—which often includes surprises like reagent markups, administrative fees, and handling charges—CPRR consolidates all costs into one clear number.
📊 CPRR Formula
CPRR = (Total Test Volume × FSS CPT Price) / Patient Result Volume
Where Total Test Volume = Calibrator Tests + QC Tests + Patient Tests + 10% Repeat Tests. The key is transparency: you know exactly what a reportable result costs.
CPRR vs. Traditional Lab Billing
| Aspect | Traditional Billing | CPRR Pricing |
|---|---|---|
| Price Structure | Variable: base test + reagents + admin + handling | Fixed: all-in price per reportable result |
| Transparency | Often opaque; bills itemize obscure charges | Single line item; simple budget forecasting |
| Predictability | High; bills vary based on reagent costs and surcharges | Very high; costs fixed regardless of market conditions |
| Volume Discounts | Negotiated separately; often vague | Baked into CPRR formula based on your volume |
| Risk to Lab | Clinic bears risk of price increases | Lab bears cost risk; aligns incentives |
Why CPRR Matters for Your Budget
Consider a real-world example: A 500-bed urgent care network running 50 STI NAAT tests per day (250/week) faces wildly variable lab bills under traditional pricing:
- Base test cost: $8–12 per result
- Reagent markup: +$3–5
- Administrative handling: +$2–3
- Rush processing (urgent care often pays this): +$5–10
- Patient EOB shows: $50–60 per test (clinic reimbursement varies widely)
Under CPRR, that same clinic locks in $15–18 per reportable result, eliminates surprise billing, and can accurately forecast monthly lab spend. At volume, that's a 60–70% cost reduction and predictable budgeting.
The Hidden Costs of Fragmented Lab Sourcing
Pre-Analytic Waste
When tests are routed to multiple labs without coordination, you incur:
- Specimen degradation in transit – Longer handling times = higher reject rates
- Re-collection costs – Rejected specimens require patient follow-up and new collection
- Staff overhead – Nurses/MAs spend time managing multiple lab portals, different requisite formats, separate result delivery channels
Billing Overhead
Multiple lab partners mean:
- Multiple invoices to reconcile each month
- Different billing cycles and coding standards (CPT codes vary by lab)
- Chargebacks and denials from inconsistent billing formats
- Dedicated staff time (or third-party service fees) to audit and reconcile
TAT Bottlenecks
Without a routing strategy, urgent care centers default to send-out labs, which average 7+ days turnaround. This translates to:
- Delayed treatment initiation (STI treatment delays → disease progression)
- Patient follow-up calls to notify results (staff time, retention risk)
- Increased patient anxiety and compliance issues
- Potential regulatory exposure (some state health codes require result delivery SLAs)
What to Look for in a Lab Partner
1. Service Level Agreements (SLAs)
Don't accept "best-effort" promises. Require contractual SLAs specifying:
- Turnaround time guarantees – "98% of results within 2 business days" (or faster)
- Reject rate thresholds – "Reject rate ≤ 2%"
- Redraw policies – Who pays if specimen fails QC?
- Penalties for missed SLAs – Service credits or fee reductions
💡 Pro Tip
SLAs with financial penalties are not common in traditional lab contracts, but they are negotiable—especially at volume. Labs with confidence in their processes will accept accountability.
2. Transparent CPRR Pricing
Ask for:
- All-in CPRR quote – Single price per reportable result (includes collection, transport, processing, reporting)
- Volume-based pricing – How does price scale from 100 to 1,000+ tests/month?
- No hidden surcharges – Confirm there are no rush fees, weekend fees, or billing adjustments
- Annual price caps – What's the maximum annual increase?
3. Real-Time Tracking & Reporting
Demand operational transparency:
- Order status dashboard – Track specimen from receipt through reporting
- TAT monitoring – Real-time metrics on turnaround time performance
- Reject rate reports – Monthly breakdowns by rejection reason
- Compliance reporting – SLA attainment, trending data
4. HIPAA Compliance & Data Security
Non-negotiable requirements:
- CLIA-certified lab operations
- Encrypted specimen tracking and result delivery
- Business Associate Agreement (BAA) in place
- Audit logs for all data access
- Incident response plan (in writing)
5. Specimen Routing Logic
If considering multi-lab routing, ask:
- How are specimens routed? Is it automated based on capacity and TAT, or manual?
- What if a lab goes down? Is there automatic failover to a backup lab?
- Can you specify preferences? (e.g., prioritize local labs, or mandate fastest TAT)
- Unified reporting – Do results come from one portal regardless of processing lab?
Building Your Evaluation Framework
Step 1: Quantify Your Current Spend
Audit your past 12 months of lab billing:
- Total tests submitted (by test type: CT, NG, TV, combo panels)
- Total lab spend (invoice audit)
- Cost per reportable result (calculated)
- Average TAT (extract from result dates)
- Reject rate (calculate from redraw incidents)
Step 2: Define Your Priorities
Rank what matters most to your clinic:
| Priority | Target Metric | Weighting |
|---|---|---|
| Cost reduction | Target CPRR savings (e.g., reduce by 30%) | High |
| Speed | TAT ≤ 2 business days for 98% of tests | High |
| Reliability | Reject rate ≤ 2% with SLA penalties | Medium |
| Operational ease | Single portal, unified reporting, API integration | Medium |
Step 3: Request Pilot Programs
Don't commit to a full contract immediately. Propose:
- 30–90 day pilot with a representative sample of specimens (e.g., 100–200 tests)
- Real performance data: actual TAT, reject rate, cost per result
- No termination penalty during pilot (or limited commitment)
- Post-pilot review meeting to discuss results and next steps
Step 4: Document Everything
Before signing any contract, have legal review:
- Pricing terms – CPRR, volume tiers, price adjustments
- SLA terms – TAT, reject rate, penalties, dispute resolution
- Data handling – HIPAA BAA, data ownership, security audit rights
- Termination clause – Notice period, exit costs, data retrieval
- Specimen routing rules – If multi-lab, what happens in failover scenarios?
Benchmarking: What Should You Expect?
Based on industry standards (CDC guidelines, FQHC networks, urgent care chain data):
- CPRR pricing – $12–25 per reportable result for high-volume clinics (depends on local market, lab overhead)
- TAT – 1–3 business days for in-network send-out labs; near real-time for POC testing (if available)
- Reject rate – 1–3% is industry standard; <2% is achievable with proper specimen handling training
- SLA compliance – Expect 95%+ on-time delivery for reliable labs
🔍 Reality Check
If a lab quotes $40+ per reportable result or guarantees 1-day TAT for all tests, verify their claims with references. Pricing that seems too good or TAT targets that seem impossible should be scrutinized.
Key Takeaways
- CPRR pricing is transparent. One fixed price per reportable result = predictable budgeting and 30–70% cost savings vs. traditional billing.
- Fragmented sourcing is expensive. Pre-analytic waste, billing overhead, and TAT delays cost more than you think. A coordinated routing strategy pays for itself.
- SLAs matter. Don't accept "best effort"—demand contractual guarantees with penalties. Labs that stand behind their performance are partners worth keeping.
- Transparency and data are your leverage. Quantify your spend, track performance metrics, and use real data to negotiate better terms.
- Pilot before committing. 30–90 day pilots de-risk transitions and give you real performance data to compare.
Next Steps
If you're ready to optimize your STI lab sourcing:
- Audit your current spend – Calculate your true cost per reportable result today
- Define your priorities – What matters most: cost, speed, reliability, or ease?
- Request CPRR quotes – Ask potential partners for all-in pricing and SLA terms
- Run a pilot – Test a new partnership on a limited volume before full commitment
- Track metrics – Monitor TAT, reject rates, and cost performance against your targets
Ready to Optimize Your Lab Routing?
Get a custom cost-per-reportable-result quote tailored to your test volume and operational needs.
Get Your Custom QuoteNext step: Ready to evaluate specific vendors? Use our Lab Partner Evaluation Checklist to score and compare candidates.
Speed benchmarks: Understand what TAT to demand and how to enforce it — see the STI Testing Turnaround Time Guide.